Index | Hypertension goal achievement % (N) | LDL-C goal achievement % (N) | Both BP and LDL-C goal achievement % (N) |
---|---|---|---|
Total (n = 17,096) Age (years) | 31.9% (5450) | 60.1% (10,281) | 22.9% (3971) |
≥ 65 (n = 9769) | 34.6% (3377) | 58.6% (5726) | 23.6% (2302) |
< 65 (n = 7327) | 28.3% (2073) | 62.2% (4555) | 22.0% (1615) |
P-value | < 0.001 | < 0.001 | 0.019 |
Duration of Hypertensiona (years) | |||
< 5 (n = 5036) | 34.8% (1754) | 63.8% (3212) | 26.0% (1310) |
≥ 5 (n = 10,588) | 32.9% (3485) | 58.8% (6225) | 23.2% (2460) |
P-value | 0.018 | < 0.001 | 0.001 |
BMI ≥ 28 kg/m2b | |||
Yes (n = 2658) | 25.1% (667) | 55.8% (1482) | 17.4% (462) |
No (n = 14,432) | 33.1% (4779) | 60.9% (8794) | 23.9% (3451) |
P-value | < 0.001 | < 0.001 | < 0.001 |
Smoking | |||
Current smoker (n = 2105) | 27.9% (587) | 59.4% (1250) | 20.0% (422) |
Previous smoker (n = 3099) | 28.3% (876) | 63.6% (1972) | 20.4% (631) |
Non-smoker (n = 11,892) | 33.5% (3987) | 59.4% (7059) | 24.1% (2864) |
P-value | < 0.001 | 0.001 | < 0.001 |
Drinking alcohol | |||
Yes (n = 1572) | 24.6% (387) | 59.2% (931) | 19.0% (298) |
No (n = 13,795) | 33.4% (4602) | 60.1% (8285) | 23.8% (3288) |
Gave up drinking (n = 1729) | 26.7% (461) | 61.6% (1065) | 19.1% (331) |
P-value | < 0.001 | 0.347 | < 0.001 |
Sedentary lifestyleb | |||
Yes (n = 3595) | 29.3% (1054) | 58.0% (2086) | 19.8% (712) |
No (n = 13,500) | 32.6% (4396) | 60.7% (8195) | 23.7% (3205) |
P-value | 0.000 | 0.004 | < 0.001 |
Family history of cardiovascular diseaseb | |||
Yes (n = 1744) | 32.7% (570) | 60.8% (1060) | 23.2% (404) |
No (n = 15,348) | 31.8% (4879) | 60.1% (9218) | 22.9% (3513) |
P-value | 0.448 | 0.561 | 0.795 |
Comorbidities | |||
CKD (n = 1502) | 19.8% (297) | 59.3% (890) | 14.8% (222) |
Diabetes (n = 6289) | 16.8% (1059) | 46.0% (2895) | 9.3% (583) |
CHD (n = 6958) | 20.3% (1410) | 54.9% (3821) | 12.8% (889) |
CVD (n = 3363) | 28.4% (956) | 53.3% (1793) | 16.8% (566) |
Heart failure (n = 757) | 25.8% (198) | 58.9% (452) | 17.1% (131) |
Peripheral vascular disease (n = 215) | 22.3% (48) | 55.3% (119) | 13.5% (29) |
P-value | < 0.001 | < 0.001 | < 0.001 |
Number of comorbidities | |||
0 (n = 4597) | 58.8% (2703) | 76.7% (3525) | 48.3% (2219) |
1 (n = 7522) | 24.3% (1830) | 57.0% (4289) | 15.3% (1152) |
2 (n = 3659) | 18.3% (670) | 50.8% (1860) | 11.0% (403) |
≥ 3 (n = 1318) | 18.7% (247) | 46.1% (607) | 10.8% (143) |
P-value | < 0.001 | < 0.001 | < 0.001 |
Tier of Hospitals | |||
Tier 1 (n = 4117) | 36.0% (1483) | 55.3% (2277) | 24.6% (1011) |
Tier 2 (n = 4433) | 32.1% (1424) | 60.3% (2672) | 22.9% (1014) |
Tier 3 (n = 8546) | 29.8% (2543) | 62.4% (5332) | 22.1% (1892) |
P-value | < 0.001 | 0.010 | 0.010 |
Department | |||
General medicine (n = 4476) | 34.0% (1520) | 53.1% (2375) | 21.5% (963) |
Geriatric (n = 2034) | 36.9% (750) | 65.9% (1341) | 27.8% (566) |
Endocrine (n = 2246) | 19.9% (446) | 48.9% (1098) | 12.4% (278) |
Neurology (n = 2062) | 28.5% (588) | 58.6% (1208) | 19.5% (402) |
Cardiology (n = 5079) | 32.0% (1626 | 67.8% (3444) | 25.2% (1282) |
Otherc(n = 1199) | 43.4% (520) | 68.0% (815) | 35.5% (426) |
P-value | < 0.001 | < 0.001 | < 0.001 |
Hypertension treatment | |||
Monotherapy (n = 8641) | 36.2% (3125) | 58.9% (5091) | 25.9% (2241) |
Combination therapy (n = 6732) | 32.4% (2184) | 63.4% (4268) | 23.6% (1591) |
P-value | < 0.001 | < 0.001 | < 0.001 |